67 participants
Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-27
- Start Date:
- 2015-11-06
- Completion:
- 2025-04-23
Conditions
- Gastric Neuroendocrine Carcinoma
- Intestinal Neuroendocrine Carcinoma
- Pancreatic Neuroendocrine Carcinoma
Interventions
- DRUG
- OTHER